ERBB2 and triple-negative breast carcinoma: Finally, patients lacking receptors for estrogen, progesterone and also lacking over-expression of HER2 (triple negative breast cancer) have currently fever options for therapy apart from chemotherapy and, more recently, PARP inhibitors for some patients.